Can anyone believe even after all the issues with Tamiflu that they are killing Relenza in the retail market? It may take LANI to knock Tamiflu off the top.
"The SDI report found that Tamiflu, the antiviral drug made by Swiss drug company Hoffmann-La Roche Ltd., accounted for more than 502,000 antiviral prescriptions filled last week. GlaxoSmithKline’s Relenza accounted for about 8,200 antiviral prescriptions."
http://philadelphia.bizjournals.com/philadelphia/blogs/health_care/2009/10/sdi_says_antiviral_prescriptions_increasing_with_swine_flu_concerns.html#
- Forums
- ASX - By Stock
- BTA
- you just have to read this article
you just have to read this article
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online